List of works - Andrew Loblaw

"TREXIT 2020": why the time to abandon transrectal prostate biopsy starts now

scientific article published on 13 January 2020

Accuracy of survival prediction by palliative radiation oncologists.

scientific article

Combining urinary DNA methylation and cell-free microRNA biomarkers for improved monitoring of prostate cancer patients on active surveillance

scientific article published on 16 February 2019

Communication with referring physicians in a palliative radiotherapy clinic

scientific article published on 01 September 2004

Computed tomography (CT) evaluation of breast cancer patients with osteolytic bone metastases undergoing palliative radiotherapy--a feasibility study

scientific article published on 01 March 2004

Determining the incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: results from three canadian cancer centers

scientific article published on 23 January 2009

Dexamethasone for the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a pilot study

scientific article published on 23 January 2007

Dosimetric impact of inter-observer catheter reconstruction variability in ultrasound-based high-dose-rate prostate brachytherapy.

scientific article published on 24 November 2017

Focal Salvage High Dose-Rate Brachytherapy for Locally Recurrent Prostate Cancer After Primary Radiation Therapy Failure: Results From a Prospective Clinical Trial

scientific article published on 02 July 2018

Impact of Magnetic Resonance Imaging on Gross Tumor Volume Delineation in Non-spine Bony Metastasis Treated With Stereotactic Body Radiation Therapy

scientific article published on 17 March 2018

In Reply to Kishan et al

scientific article published on 11 November 2015

Intraoperative ultrasound-based planning can effectively replace postoperative CT-based planning for high-dose-rate brachytherapy for prostate cancer.

scientific article published on 11 May 2016

MRI assisted focal boost integrated with HDR monotherapy study in low and intermediate risk prostate cancer (MARS): Results from a phase II clinical trial

scientific article published on 26 September 2019

Multidisciplinary radiation oncology palliative care rounds as a continuing educational activity implementing the rapid response radiotherapy program at the toronto sunnybrook regional cancer centre

scientific article published on 01 January 2003

Pattern of relapse and dose received by the recurrent intraprostatic nodule in low- to intermediate-risk prostate cancer treated with single fraction 19 Gy high dose-rate brachytherapy.